Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer
Deciphering molecular pathways involved in the early steps of prostate oncogenesis requires both in vitro and in vivo models derived from human primary tumors. However the few recognized models of human prostate epithelial cancer originate from metastases. To date, very few models are proposed from...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | JOUR |
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00144827_v317_n3_p262_Chauchereau |
| Aporte de: |
| id |
todo:paper_00144827_v317_n3_p262_Chauchereau |
|---|---|
| record_format |
dspace |
| spelling |
todo:paper_00144827_v317_n3_p262_Chauchereau2023-10-03T14:12:40Z Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer Chauchereau, A. Al Nakouzi, N. Gaudin, C. Le Moulec, S. Compagno, D. Auger, N. Bénard, J. Opolon, P. Rozet, F. Validire, P. Fromont, G. Fizazi, K. Basal epithelial cells Gene expression profiling Prostatic neoplasms Tumor cells cultured Tumor stem cells 2 methylacyl coenzyme A racemase cytokeratin 14 cytokeratin 5 octamer transcription factor 4 prostate specific membrane antigen protein p53 sonic hedgehog protein telomerase very late activation antigen 2 adult animal cell animal experiment animal tissue article cancer cell culture cancer growth cancer stem cell case report cell structure controlled study enzyme activity epithelium cell extracellular matrix gene mutation human human cell IGR CaP1 cell male mouse nonhuman priority journal prostate cancer protein expression signal transduction tetraploidy Animalia Erinaceidae Mus Mus musculus Deciphering molecular pathways involved in the early steps of prostate oncogenesis requires both in vitro and in vivo models derived from human primary tumors. However the few recognized models of human prostate epithelial cancer originate from metastases. To date, very few models are proposed from primary tumors and immortalizing normal human prostate cells does not recapitulate the natural history of the disease. By culturing human prostate primary tumor cells onto human epithelial extra-cellular matrix, we successfully selected a new prostate cancer cell line, IGR-CaP1, and clonally-derived subclones. IGR-CaP1 cells, that harbor a tetraploid karyotype, high telomerase activity and mutated TP53, rapidly induced subcutaneous xenografts in nude mice. Furthermore, IGR-CaP1 cell lines, all exhibiting negativity for the androgen receptor and PSA, express the specific prostate markers alpha-methylacyl-CoA racemase and a low level of the prostate-specific membrane antigen PSMA, along with the prostate basal epithelial markers CK5 and CK14. More importantly, these clones express high CD44, CD133, and CXCR4 levels associated with high expression of α2β1-integrin and Oct4 which are reported to be prostate cancer stemness markers. RT-PCR data also revealed high activation of the Sonic Hedgehog signalling pathway in these cells. Additionally, the IGR-CaP1 cells possess a 3D sphere-forming ability and a renewal capacity by maintaining their CSC potential after xenografting in mice. As a result, the hormone-independent IGR-CaP1 cellular clones exhibit the original features of both basal prostate tissue and cancer stemness. Tumorigenic IGR-CaP1 clones constitute invaluable human models for studying prostate cancer progression and drug assessment in vitro as well as in animals specifically for developing new therapeutic approaches targeting prostate cancer stem cells. © 2010 Elsevier Inc. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00144827_v317_n3_p262_Chauchereau |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| topic |
Basal epithelial cells Gene expression profiling Prostatic neoplasms Tumor cells cultured Tumor stem cells 2 methylacyl coenzyme A racemase cytokeratin 14 cytokeratin 5 octamer transcription factor 4 prostate specific membrane antigen protein p53 sonic hedgehog protein telomerase very late activation antigen 2 adult animal cell animal experiment animal tissue article cancer cell culture cancer growth cancer stem cell case report cell structure controlled study enzyme activity epithelium cell extracellular matrix gene mutation human human cell IGR CaP1 cell male mouse nonhuman priority journal prostate cancer protein expression signal transduction tetraploidy Animalia Erinaceidae Mus Mus musculus |
| spellingShingle |
Basal epithelial cells Gene expression profiling Prostatic neoplasms Tumor cells cultured Tumor stem cells 2 methylacyl coenzyme A racemase cytokeratin 14 cytokeratin 5 octamer transcription factor 4 prostate specific membrane antigen protein p53 sonic hedgehog protein telomerase very late activation antigen 2 adult animal cell animal experiment animal tissue article cancer cell culture cancer growth cancer stem cell case report cell structure controlled study enzyme activity epithelium cell extracellular matrix gene mutation human human cell IGR CaP1 cell male mouse nonhuman priority journal prostate cancer protein expression signal transduction tetraploidy Animalia Erinaceidae Mus Mus musculus Chauchereau, A. Al Nakouzi, N. Gaudin, C. Le Moulec, S. Compagno, D. Auger, N. Bénard, J. Opolon, P. Rozet, F. Validire, P. Fromont, G. Fizazi, K. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer |
| topic_facet |
Basal epithelial cells Gene expression profiling Prostatic neoplasms Tumor cells cultured Tumor stem cells 2 methylacyl coenzyme A racemase cytokeratin 14 cytokeratin 5 octamer transcription factor 4 prostate specific membrane antigen protein p53 sonic hedgehog protein telomerase very late activation antigen 2 adult animal cell animal experiment animal tissue article cancer cell culture cancer growth cancer stem cell case report cell structure controlled study enzyme activity epithelium cell extracellular matrix gene mutation human human cell IGR CaP1 cell male mouse nonhuman priority journal prostate cancer protein expression signal transduction tetraploidy Animalia Erinaceidae Mus Mus musculus |
| description |
Deciphering molecular pathways involved in the early steps of prostate oncogenesis requires both in vitro and in vivo models derived from human primary tumors. However the few recognized models of human prostate epithelial cancer originate from metastases. To date, very few models are proposed from primary tumors and immortalizing normal human prostate cells does not recapitulate the natural history of the disease. By culturing human prostate primary tumor cells onto human epithelial extra-cellular matrix, we successfully selected a new prostate cancer cell line, IGR-CaP1, and clonally-derived subclones. IGR-CaP1 cells, that harbor a tetraploid karyotype, high telomerase activity and mutated TP53, rapidly induced subcutaneous xenografts in nude mice. Furthermore, IGR-CaP1 cell lines, all exhibiting negativity for the androgen receptor and PSA, express the specific prostate markers alpha-methylacyl-CoA racemase and a low level of the prostate-specific membrane antigen PSMA, along with the prostate basal epithelial markers CK5 and CK14. More importantly, these clones express high CD44, CD133, and CXCR4 levels associated with high expression of α2β1-integrin and Oct4 which are reported to be prostate cancer stemness markers. RT-PCR data also revealed high activation of the Sonic Hedgehog signalling pathway in these cells. Additionally, the IGR-CaP1 cells possess a 3D sphere-forming ability and a renewal capacity by maintaining their CSC potential after xenografting in mice. As a result, the hormone-independent IGR-CaP1 cellular clones exhibit the original features of both basal prostate tissue and cancer stemness. Tumorigenic IGR-CaP1 clones constitute invaluable human models for studying prostate cancer progression and drug assessment in vitro as well as in animals specifically for developing new therapeutic approaches targeting prostate cancer stem cells. © 2010 Elsevier Inc. |
| format |
JOUR |
| author |
Chauchereau, A. Al Nakouzi, N. Gaudin, C. Le Moulec, S. Compagno, D. Auger, N. Bénard, J. Opolon, P. Rozet, F. Validire, P. Fromont, G. Fizazi, K. |
| author_facet |
Chauchereau, A. Al Nakouzi, N. Gaudin, C. Le Moulec, S. Compagno, D. Auger, N. Bénard, J. Opolon, P. Rozet, F. Validire, P. Fromont, G. Fizazi, K. |
| author_sort |
Chauchereau, A. |
| title |
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer |
| title_short |
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer |
| title_full |
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer |
| title_fullStr |
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer |
| title_full_unstemmed |
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer |
| title_sort |
stemness markers characterize igr-cap1, a new cell line derived from primary epithelial prostate cancer |
| url |
http://hdl.handle.net/20.500.12110/paper_00144827_v317_n3_p262_Chauchereau |
| work_keys_str_mv |
AT chauchereaua stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT alnakouzin stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT gaudinc stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT lemoulecs stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT compagnod stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT augern stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT benardj stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT opolonp stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT rozetf stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT validirep stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT fromontg stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer AT fizazik stemnessmarkerscharacterizeigrcap1anewcelllinederivedfromprimaryepithelialprostatecancer |
| _version_ |
1807319638528229376 |